← Back to Search

IIMR vs CDSMP for Mental Health Disorders

N/A

Recruiting

Led By Sarah Pratt

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare two different interventions for people with serious mental illness to see which is more effective.

Who is the study for?

This trial is for people with serious mental illnesses like schizophrenia or bipolar disorder, who also have a chronic physical condition such as diabetes or heart disease. They should have had an ER visit or hospitalization in the past year and need help managing their health. It's only for those receiving services at Centerstone in KY or TN and who speak English.

What is being tested?

The study compares two programs: I-IMR, which helps people with serious mental illness manage both physical and mental health, and CDSMP, focused on managing physical health conditions. The goal is to see which program better supports individuals' self-management of their chronic diseases.

What are the potential side effects?

Since this trial involves educational interventions rather than medications, traditional side effects are not applicable. However, participants may experience stress or discomfort when discussing personal health issues during the programs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a serious mental illness and am getting help from Centerstone in KY or TN.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Acute Hospital Events from Electronic Medical Record Review.

Change in Knowledge and skills in illness self-management using the Illness Management and Recovery Scale

Change in Patient Activation on the Patient Activation Measure (PAM)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Stanford Chronic Disease Self-Management Program (CDSMP):Experimental Treatment1 Intervention

Participants randomly assigned get a 6-session group-based educational program co-delivered by two peers (lay people who have successfully managed a chronic illness) or a peer and a professional

Group II: Integrated Illness Management and Recovery (I-IMR):Experimental Treatment1 Intervention

Participants assigned to I-IMR will receive 2 individual sessions to discuss principles of recovery and set personally meaningful goals, with the remainder of the 14 I-IMR sessions delivered in groups of 8-10 (to enable individual tailoring)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Integrated Illness Management and Recovery

2020

N/A

~170

Chronic Disease Self-Management Program

2015

N/A

~1320